IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Return 65.21%
This Quarter Return
+43.34%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
AUM
$350M
AUM Growth
+$28.2M
Cap. Flow
+$25.7M
Cap. Flow %
7.33%
Top 10 Hldgs %
41.9%
Holding
166
New
42
Increased
23
Reduced
56
Closed
16
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RNA icon
151
Avidity Biosciences
RNA
$6.24B
0
ROIV icon
152
Roivant Sciences
ROIV
$8.58B
-100,609
Closed -$1.16M
SLDB icon
153
Solid Biosciences
SLDB
$433M
0
SLN
154
Silence Therapeutics
SLN
$247M
-587,343
Closed -$3.37M
SLNO icon
155
Soleno Therapeutics
SLNO
$3.7B
-221,437
Closed -$11.2M
TEVA icon
156
Teva Pharmaceuticals
TEVA
$21.2B
0
TSN icon
157
Tyson Foods
TSN
$20B
0
VRTX icon
158
Vertex Pharmaceuticals
VRTX
$102B
0
WVE icon
159
Wave Life Sciences
WVE
$1.3B
-544,265
Closed -$4.46M
XBI icon
160
SPDR S&P Biotech ETF
XBI
$5.28B
0
ONC
161
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
-88,167
Closed -$1.64M
MRNS
162
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-706,154
Closed -$1.24M
NMRA icon
163
Neumora Therapeutics
NMRA
$264M
0
NVAX icon
164
Novavax
NVAX
$1.27B
0
NYXH
165
Nyxoah
NYXH
$214M
-50,699
Closed -$484K
PPC icon
166
Pilgrim's Pride
PPC
$10.5B
0